Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Introduction</h3><p>Perioperative use of ketamine has been discussed widely in many kinds of surgery. The aim of our study is to evaluate the short‐term and long‐term benefits and safety of ketamine after breast surgery.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Method</h3><p>We performed a quantitative systematic review. Randomized controlled trials that compared intravenous administration of ketamine to a placebo control group or bupivacaine in combination with ketamine to bupivacaine alone in thoracic paravertebral block or pectoral block for patients undergoing breast surgery and took the pain or morphine consumption as a primary or secondary outcome were included. The primary outcome was postoperative pain intensity. Secondary outcomes included cumulative opioid consumption during 0‐24‐hour postoperative period, the effect in postmastectomy pain syndrome, the effect in postoperative depression, and the adverse events associated with the use of ketamine.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Result</h3><p>13 randomized controlled trials with 1182 patients were included for analysis. Compared with placebo, intravenous ketamine was effective to reduce the wound pain intensity during the first 6 hours after the surgery (WMD ‐0.83; 95%CI‐1.65, ‐0.01; p=0.048) and during the first 24 hours after the surgery(WMD ‐0.65; 95%CI, ‐0.95, ‐0.35; p<0.001), and decrease the opioid consumption(WMD ‐4.14; 95%CI ‐8.00, ‐0.29; p=0.035) for the first 24 hours after the surgery, without increasing the risks of gastrointestinal and CNS adverse events. Adding ketamine to bupivacaine in thoracic paravertebral block was also effective to reduce the postoperative wound pain during the 6 hours after the surgery (WMD ‐0.59; 95%CI, ‐1.06, ‐0.12; p=0.014) and during the first 24 hours after the surgery(WMD ‐0.90; 95%CI, ‐1.27, ‐0.53, p<0.001), and decrease the opioid consumption(WMD ‐4.59; 95%CI ‐5.76, ‐3.42; p<0.001) for the first 24 hours after the surgery. Perioperative use of ketamine was associated with improved postoperative depression symptoms (SMD ‐0.80; 95%CI ‐1.34, ‐0.27; p=0.003) and less incidence of postmastectomy pain syndrome (RR 0.79; 95%CI 0.63,0.99; p=0.043).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>Ketamine is an effective and safe multimodal analgesic in patients undergoing breast surgery both intravenously and adding to bupivacaine in paravertebral block. Besides, ketamine showed long‐term benefit for preventing postoperative depression and postmastectomy pain syndrome.</p></section>

[Postmastectomy analgesia with subcutaneous infiltration of ketamine with lidocaine in surgical wound]

Effects of Local Wound Infiltration Post-Mastectomy Using Bupivacaine Alone, Bupivacaine With Ketamine, and Bupivacaine With Dexmedetomidine: A Randomized Double-Blind Study

Subcutaneous wound infiltration of ketamine is superior to bupivacaine in terms of pain perception and opioid consumption after cesarean section: a double-blinded randomized placebo-controlled clinical trial

A Comparison Between the Effectiveness of Ketamine Bolus and Intradermal Lidocaine in Reducing Acute Postoperative Pain

Combined Ketamine-Tramadol Subcutaneous Wound Infiltration for Multimodal Postoperative Analgesia: A Double-Blinded, Randomized Controlled Trial after Renal Surgery

Effect of local wound infiltration with ketamine versus dexmedetomidine on postoperative pain and stress after abdominal hysterectomy, a randomized trial

The Effect of Ketamine on Acute and Chronic Wound Pain in Patients Undergoing Breast Surgery: A Meta‐Analysis and Systematic Review

Postoperative Analgesic Effect of Using Bupivacaine Versus Bupivacaine with Dexmedetomidine or Ketamine in Cesarean Section Operations

Is the Effect of Inguinal Field Block With 0.5% Bupivacaine on Postoperative Pain After Hernia Repair Enhanced by Addition of Ketorolac or S(+) Ketamine?

Nalbuphine Versus Ketorolac as an Adjuvant to Local Wound Infiltration Anesthesia in Open Colorectal Surgery: A Prospective Randomized Controlled Study

Ketamine infiltration improves analgesia after thyroid surgery

S-ketamine Infusion on Chronic Postoperative Pain Following Breast Cancer Surgery: A Randomized Double-Blind Placebo-Controlled Trial

Intraperitoneal instillation versus wound infiltration for postoperative pain relief after cesarean delivery: A prospective, randomized, double‐blind, placebo‐controlled trial

Efficacy and safety of ketamine wound infiltration for postoperative pain management: A systematic review, meta-analysis and trial sequential analysis

S-Ketamine attenuates inflammatory effect and modulates the immune response in patients undergoing modified radical mastectomy: A prospective randomized controlled trial

[Efficacy of transdermal lidocaine 5% patches in postoperative analgesia following knee arthroscopy]

Subcutaneous ketamine prolongs the analgesic effect of local infiltration of plain Bupivacaine in children undergoing inguinal herniotomy

Efficiency of intravenous infusion of ketamine and lidocaine as part of multimodal analgesia in the postoperative period in children

Optimizing the use of ketamine to reduce chronic postsurgical pain in women undergoing mastectomy for oncologic indication: study protocol for the KALPAS multicenter randomized controlled trial

Local anaesthetic wound infiltration for postcaesarean section analgesia: A systematic review and meta-analysis

[Effects of Preincisional Epidural Administration of Lidocaine and Fentanyl on Postoperative Pain Management Following Hysterectomy].